Adagio(IVVD) - 2024 Q2 - Earnings Call Transcript

Invivyd, Inc. (NASDAQ:IVVD) Q2 2024 Earnings Conference Call August 14, 2024 8:30 AM ET Company Participants Katie Falzone - VP, Corporate Controller Marc Elia - Chairperson, Board of Directors and Executive Committee Tim Lee - Chief Commercial Officer Bill Duke - CFO Robert Allen - Chief Scientific Officer Mark Wingertzahn - SVP of Clinical Development and Medical Affairs. Conference Call Participants Boran Wang - Guggenheim Securities Maxwell Skor - Morgan Stanley Operator Good day, and welcome to the Sec ...